19 November 2017
News and Views
Links and Services
March's issue of the Alimentary Pharmacology & Therapeutics reports on long-term outcomes of thalidomide in refractory Crohn's disease.
Several open-label and retrospective studies have indicated that thalidomide may be beneficial in
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors